Modified Spike SARS-CoV-2 mRNA
|Description||Spike protein of SARS-CoV-2 virus mRNA does not bear any additional nucleotide modifications while is modified with 5-methoxyuridine (5moU) to reduce innate immune responses.|
|Concentration||1.0 mg/mL in 1 mM Sodium Citrate, pH 6.4.|
|Applications||Spike SARS CoV-2 mRNAs have been designed to produce high expression level of spike protein of SARS-CoV-2 virus.|
For research use only. Not intended for any clinical use.